{"id":"https://openalex.org/W2085347131","doi":"https://doi.org/10.1089/cap.2005.15.325","title":"Retrospective Assessment of Atomoxetine in Children and Adolescents with Pervasive Developmental Disorders","display_name":"Retrospective Assessment of Atomoxetine in Children and Adolescents with Pervasive Developmental Disorders","alternate_titles":[],"publication_year":2005,"publication_date":"2005-04-01","ids":{"openalex":"https://openalex.org/W2085347131","doi":"https://doi.org/10.1089/cap.2005.15.325","mag":"2085347131","pmid":"https://pubmed.ncbi.nlm.nih.gov/15910217"},"language":"en","primary_location":{"id":"doi:10.1089/cap.2005.15.325","doi":"https://doi.org/10.1089/cap.2005.15.325","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2005.15.325","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2085347131"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035888663","display_name":"Roger J. Jou","orcid":"https://orcid.org/0000-0002-7501-7865","observed_orcids":["https://orcid.org/0000-0002-7501-7865"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roger J. Jou","raw_affiliation_strings":["Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut","Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut","institution_ids":["https://openalex.org/I32971472"]},{"raw_affiliation_string":"Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008552659","display_name":"Benjamin L. Handen","orcid":"https://orcid.org/0000-0001-9550-1665","observed_orcids":["https://orcid.org/0000-0001-9550-1665"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Benjamin L. Handen","raw_affiliation_strings":["Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048800466","display_name":"Antonio Y. Hardan","orcid":"https://orcid.org/0000-0002-9860-8625","observed_orcids":["https://orcid.org/0000-0002-9860-8625"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Antonio Y. Hardan","raw_affiliation_strings":["Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania","institution_ids":["https://openalex.org/I170201317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.5614,"has_fulltext":false,"cited_by_count":72,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.88164948,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"15","issue":"2","first_page":"325","last_page":"330"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10106","display_name":"Autism Spectrum Disorder Research","score":0.5195000171661377,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10106","display_name":"Autism Spectrum Disorder Research","score":0.5195000171661377,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.4641000032424927,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11772","display_name":"Genetics and Neurodevelopmental Disorders","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atomoxetine","display_name":"atomoxetine","score":1.0},{"id":"https://openalex.org/keywords/pervasive-developmental-disorders","display_name":"pervasive developmental disorders","score":0.9909999966621399},{"id":"https://openalex.org/keywords/autism-spectrum-disorder","display_name":"autism spectrum disorder","score":0.843999981880188},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.30300000309944153},{"id":"https://openalex.org/keywords/children-and-adolescents","display_name":"children and adolescents","score":0.765999972820282},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.8149999976158142},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.9440000057220459},{"id":"https://openalex.org/keywords/mood-swings","display_name":"mood swings","score":0.6510000228881836},{"id":"https://openalex.org/keywords/hyperactivity","display_name":"hyperactivity","score":0.6179999709129333},{"id":"https://openalex.org/keywords/inattention","display_name":"inattention","score":0.890999972820282},{"id":"https://openalex.org/keywords/conduct-problems","display_name":"conduct problems","score":0.6700000166893005},{"id":"https://openalex.org/keywords/learning","display_name":"learning","score":0.4749999940395355},{"id":"https://openalex.org/keywords/concomitant-medications","display_name":"concomitant medications","score":0.5600000023841858}],"concepts":[{"id":"https://openalex.org/C2778781522","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine","level":4,"score":0.9286657571792603},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7950805425643921},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.5838979482650757},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.5521308183670044},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.5324315428733826},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5267980694770813},{"id":"https://openalex.org/C2909253567","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine hydrochloride","level":5,"score":0.48619598150253296},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47655537724494934},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.4601168930530548},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.4426094591617584},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42546790838241577},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.42167115211486816},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.41519567370414734},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4116951525211334},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.33711937069892883},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23694223165512085},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.15674984455108643},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069445","descriptor_name":"Atomoxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002659","descriptor_name":"Child Development Disorders, Pervasive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002659","descriptor_name":"Child Development Disorders, Pervasive","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/cap.2005.15.325","doi":"https://doi.org/10.1089/cap.2005.15.325","is_oa":false,"landing_page_url":"https://doi.org/10.1089/cap.2005.15.325","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:15910217","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15910217","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of child and adolescent psychopharmacology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G430809876","display_name":"NEUROIMAGING/DEVELOPMENTAL NEUROBIOLOGY OF AUTISM","funder_award_id":"K23MH064027","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W73658022","https://openalex.org/W1498586118","https://openalex.org/W2027846886","https://openalex.org/W2034469737","https://openalex.org/W2064396657","https://openalex.org/W2123980944","https://openalex.org/W2737496409"],"related_works":["https://openalex.org/W1974043145","https://openalex.org/W2160781842","https://openalex.org/W2015829627","https://openalex.org/W2062789857","https://openalex.org/W3006672350","https://openalex.org/W2117095140","https://openalex.org/W2083338868","https://openalex.org/W2933291477","https://openalex.org/W2033673747","https://openalex.org/W1992714410"],"abstract_inverted_index":{"A":[0],"retrospective":[1],"study":[2],"was":[3,30,57,120,128],"conducted":[4],"to":[5,32,138,213],"assess":[6,214],"the":[7,60,65,73,90,151,157,160,166,180],"effectiveness":[8],"and":[9,15,36,84,99,126,156,173,182,204,217],"tolerability":[10],"of":[11,26,44,64,146,159,190,202],"atomoxetine":[12,40,188],"in":[13,89,165,179],"children":[14,35],"adolescents":[16,37],"with":[17,28],"pervasive":[18],"developmental":[19],"disorders":[20],"(PDD).":[21],"An":[22],"outpatient":[23],"clinic":[24],"registry":[25],"individuals":[27],"PDD":[29],"used":[31],"identify":[33],"all":[34],"who":[38],"received":[39],"over":[41],"a":[42,144],"period":[43,162],"12":[45],"months.":[46],"Patients":[47],"were":[48,94,111,136,163,177],"included":[49],"if":[50],"concomitant":[51,116],"medications":[52],"remained":[53],"unchanged.":[54],"Treatment":[55,118],"response":[56],"assessed":[58],"using":[59],"Global":[61,67],"Improvement":[62],"item":[63],"Clinical":[66],"Impressions":[68],"scale":[69],"(CGI-GI)":[70],"based":[71],"on":[72,150],"Conners":[74],"Parent":[75],"Rating":[76],"Scale":[77],"(CPRS)":[78],"routinely":[79],"completed":[80],"by":[81,143],"primary":[82],"caretakers":[83],"other":[85],"clinical":[86],"information":[87],"available":[88],"registry.":[91],"Twenty":[92],"patients":[93,109,135],"identified,":[95],"including":[96],"16":[97],"males":[98],"4":[100],"females":[101],"(age,":[102],"11.5":[103],"years;":[104],"standard":[105],"deviation,":[106,124,132],"3.5).":[107],"Most":[108],"(80%)":[110],"taking":[112],"at":[113],"least":[114],"1":[115,147],"medication.":[117],"dose":[119],"43.3":[121],"mg":[122],"(standard":[123,131],"18.1)":[125],"duration":[127],"19.5":[129],"weeks":[130],"10.5).":[133],"Twelve":[134],"judged":[137],"be":[139,196],"responders,":[140],"as":[141],"defined":[142],"score":[145],"or":[148,207],"2":[149],"CGI-GI.":[152],"Differences":[153],"between":[154],"baseline":[155],"end":[158],"trial":[161],"observed":[164],"following":[167],"CPRS":[168],"subscales:":[169],"Conduct,":[170],"hyperactivity,":[171],"inattention,":[172],"learning.":[174],"No":[175],"differences":[176],"noted":[178],"anxiety":[181],"psychosomatic":[183],"subscales.":[184],"One":[185],"patient":[186],"discontinued":[187],"because":[189],"severe":[191],"mood":[192],"swings.":[193],"Atomoxetine":[194],"may":[195],"beneficial":[197],"for":[198],"treating":[199],"secondary":[200],"symptoms":[201],"PDD,":[203],"prospective":[205],"open-label":[206],"double-blind,":[208],"placebo-controlled":[209],"studies":[210],"are":[211],"needed":[212],"its":[215],"efficacy":[216],"safety.":[218]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2085347131","counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
